- Home
- CRT vs ESLA Comparison
CRT vs ESLA Comparison
Compare CRT & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRT
- ESLA
- Stock Information
- Founded
- CRT 1991
- ESLA 2021
- Country
- CRT United States
- ESLA United States
- Employees
- CRT N/A
- ESLA N/A
- Industry
- CRT Oil & Gas Production
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CRT Energy
- ESLA Health Care
- Exchange
- CRT Nasdaq
- ESLA Nasdaq
- Market Cap
- CRT 42.5M
- ESLA 48.9M
- IPO Year
- CRT 1992
- ESLA N/A
- Fundamental
- Price
- CRT $8.75
- ESLA $2.01
- Analyst Decision
- CRT
- ESLA Strong Buy
- Analyst Count
- CRT 0
- ESLA 1
- Target Price
- CRT N/A
- ESLA $16.00
- AVG Volume (30 Days)
- CRT 39.9K
- ESLA 507.8K
- Earning Date
- CRT 01-01-0001
- ESLA 11-13-2025
- Dividend Yield
- CRT 9.04%
- ESLA N/A
- EPS Growth
- CRT N/A
- ESLA N/A
- EPS
- CRT 0.92
- ESLA N/A
- Revenue
- CRT $6,559,820.00
- ESLA N/A
- Revenue This Year
- CRT N/A
- ESLA N/A
- Revenue Next Year
- CRT N/A
- ESLA N/A
- P/E Ratio
- CRT $8.92
- ESLA N/A
- Revenue Growth
- CRT N/A
- ESLA N/A
- 52 Week Low
- CRT $7.07
- ESLA $0.73
- 52 Week High
- CRT $13.31
- ESLA $3.15
- Technical
- Relative Strength Index (RSI)
- CRT 74.91
- ESLA 48.14
- Support Level
- CRT $7.55
- ESLA $2.20
- Resistance Level
- CRT $7.80
- ESLA $3.01
- Average True Range (ATR)
- CRT 0.28
- ESLA 0.43
- MACD
- CRT 0.13
- ESLA -0.06
- Stochastic Oscillator
- CRT 78.02
- ESLA 10.83
About CRT Cross Timbers Royalty Trust
Cross Timbers Royalty Trust is a United States-based trust. The net profits interests are derived from producing royalty, overriding royalty interests, and working interest properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.